Noni para Diabetes
Morinda citrifolia — 4 estudios científicos revisados
Preliminary¿Sirve Noni para diabetes?
La investigación científica ha explorado el potencial de Noni (Morinda citrifolia) en relación con diabetes. Se han identificado 4 estudios relevantes que examinan esta relación.
Compuestos activos involucrados: xeronina, escopoletina, damnacantal, iridoides, Alcaloides, Flavonoides, Lignanos, Quercetina, Rutina, Terpeno, Terpenos
Evidencia Científica
Los siguientes estudios han investigado la relación entre Noni y diabetes:
Morinda citrifolia L. (noni) and its potential in the management of systemic metabolic disorder (SMD).
Morinda citrifolia L. (noni) is a tropical plant containing over 200 phytochemicals, including terpenoids, anthraquinones, coumarins, flavonoids, lignans, and polysaccharides, with demonstrated biological activities such as antioxidant, anti-inflammatory, hypoglycaemic, hepatoprotective, and cardioprotective effects. Studies indicate that noni and its bioactive components, such as scopoletin, quercetin, rutin, ursolic acid, and polysaccharides, exert beneficial effects on systemic metabolic disorder (SMD). SMD is a complex syndrome involving multi-organ metabolic dysregulation, characterized b
PubMed: 41243483Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction.
Cultural and economic shifts in the early 19th century led to the rapid development of companies that made good profits from technologically-produced commodities. In this way, some habits changed in society, such as the overconsumption of processed and micronutrient-poor foods and devices that gave rise to a sedentary lifestyle. These factors influenced host-microbiome interactions which, in turn, mediated the etiopathogenesis of "new-era" disorders and diseases, which are closely related, such as obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, hypertension, and inflammat
PubMed: 28587078Indian Morinda species: A review.
Morinda is a largest genus of Rubiaceae family, and its 11 species are found in India. In India, plant species are known by several common names as great morinda, Indian mulberry, noni, beach mulberry and cheese fruit. Various Morinda products (capsules, tablets, skin products and fruit juices) are available in the market, used by people for treatment of several health complaints. A diversity of phytochemicals including iridoids, flavonoids, flavonoid glycosides, anthraquinones, coumarins, lignanas, noniosides, phenolics and triterpenoids have been reported from Morinda species. Morinda specie
PubMed: 31840355Anti-Diabetic Potential of Noni: The Yin and the Yang.
Escalating trends of chronic diseases such as type-2 diabetes (T2D) have sparked a renewed interest in complementary and alternative medicine, including herbal products. Morinda citrifolia (noni) has been used for centuries by Pacific Islanders to treat various ailments. Commercial noni fruit juice has been marketed as a dietary supplement since 1996. In 2003, the European Commission approved Tahitian noni juice as a novel food by the Health and Consumer Protection Directorate General. Among noni's several health benefits, others and we have demonstrated the anti-diabetic effects of fermented
PubMed: 26404212Seguridad y Precauciones
La seguridad del uso de Noni (Morinda citrifolia) requiere una supervisión cuidadosa debido a su complejidad bioquímica y la falta de estandarización en los productos comerciales. En cuanto al embarazo y la lactancia, no existe evidencia clínica suficiente que garantice la inocuidad del consumo de noni en mujeres gestantes o lactantes; por lo tanto, su uso está contraindicado en estas etapas para evitar riesgos potenciales al desarrollo fetal o al lactante, dado que los compuestos como los iridoides y alcaloides pueden atravesar barreras biológicas. Para la población infantil, especialmente niños menores de 12 años, se recomienda evitar su administración debido a la ausencia de estudios de toxicidad pediátrica y la incertidumbre sobre el impacto en el desarrollo hormonal y metabólico en organismos en crecimiento. En el ámbito de las interacciones farmacológicas, el noni presenta riesgos significativos. Se debe evitar la combinación con la fenitoína (un anticonvulsivo de estrecho margen terapéutico), ya que estudios indican que el noni puede reducir las concentraciones plasmáticas de este fármaco a niveles subterapéuticos, lo que aumenta el riesgo de crisis convulsivas [PMID 41560756]. Asimismo, debido a su potencial efecto sobre la glucosa y la vía PI3K/AKT, su uso conjunto con fármacos para la diabetes como la metformina podría potenciar excesivamente la hipoglucemia.
Otras plantas estudiadas para Diabetes
Perfil completo: Ver todos los usos y evidencia de Noni →